Effect of nitrates on the frequency of left ventricular free wall rupture complicating acute myocardial infarction: a

H Pollak1, J Mlczoch

  • 1Ludwig Boltzmann Institut für Herzinfarktforschung and 4, Medizinische Abteilung des Krankenhauses der Stadt Wien-Lainz, Austria.

American Heart Journal
|September 1, 1994
PubMed

Insights

Nitrate therapy may reduce the risk of left ventricular free wall rupture after acute myocardial infarction. This study suggests nitrates lower rupture risk by about 30% in heart attack patients.

Area of Science:

  • Cardiology
  • Medical Research

Background:

  • Left ventricular free wall rupture is a severe complication of acute myocardial infarction (AMI), contributing to up to 33% of AMI deaths.
  • Existing data on drug efficacy in preventing this complication are limited and conflicting.

Purpose of the Study:

  • To investigate the impact of early nitrate therapy on the incidence of left ventricular free wall rupture in patients following AMI.

Main Methods:

  • A retrospective case-controlled study design.
  • Comparison of 91 patients with left ventricular free wall rupture post-AMI against 182 control patients without rupture.
  • Analysis of nitrate administration (intravenous or oral) in the initial days post-AMI.

Main Results:

  • Patients receiving nitrate therapy exhibited a reduced risk of free wall rupture.
  • The adjusted odds ratio for rupture in nitrate recipients was 0.73 (p=0.038), indicating a significant association.
  • Nitrate use was associated with an approximate 30% reduction in the risk of left ventricular free wall rupture.

Conclusions:

  • Early nitrate administration following acute myocardial infarction may be associated with a decreased frequency of left ventricular free wall rupture.
  • Nitrate therapy appears to be a potentially protective factor against this life-threatening complication.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...